Hepatitis C virus in renal disease

Area of Science:

• Nephrology
• Hepatology
• Virology

Background:

• Hepatitis C virus (HCV) is a primary cause of liver disease in patients undergoing dialysis and those who have received kidney transplants.
• An estimated 20% to 30% of the dialysis population is infected with HCV.
• HCV is implicated in the development of kidney conditions like membranoproliferative and membranous glomerulonephritis.

Purpose of the Study:

• To evaluate the diagnostic utility of current methods for Hepatitis C virus (HCV) detection in end-stage renal disease (ESRD) patients.
• To understand the natural history of HCV infection in ESRD patients, particularly after renal transplantation, using updated viral markers.

Main Methods:

• Utilized enzyme immunoassay (EIA) and recombinant immunoblot assay (RIBA) to detect antibodies against multiple HCV antigens.
• Employed polymerase chain reaction (PCR) for Hepatitis C virus RNA identification, especially post-transplantation.
• Reviewed existing literature on HCV diagnosis and natural history in the context of ESRD.

Main Results:

• EIA and RIBA are effective in diagnosing HCV infection in dialysis patients.
• Post-transplantation, HCV RNA detection via PCR is frequently necessary for accurate diagnosis.
• The long-term course of HCV infection with new markers in ESRD patients requires further definition.

Conclusions:

• Current serological tests are valuable for initial HCV diagnosis in dialysis patients.
• Molecular methods like PCR are crucial for confirming HCV infection after kidney transplantation.
• Further research is essential to define the natural history of HCV in ESRD patients with advanced diagnostic tools.